Clincosm LogoSign in Get a demo

Healthy Subjects

Showing NaN - NaN of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subjects Trial in Baltimore (KBP-7072, Placebo)

Recruiting
  • Healthy Subjects
  • Baltimore, Maryland
    Parexel International - Early Phase Clinical Unit
Aug 16, 2022

Healthy Subjects Trial in Baltimore (Fezolinetant)

Completed
  • Healthy Subjects
  • Baltimore, Maryland
    Parexel
Feb 10, 2022

Healthy Subjects Trial in Baltimore (MGD010, Placebo, Hepatitis A vaccine)

Completed
  • Healthy Subjects
  • Baltimore, Maryland
    PAREXEL Baltimore Early Phase Clinical Unit
Feb 4, 2022

Healthy Subjects Trial in Baltimore (Isavuconazonium sulfate IV, Isavuconazonium sulfate capsules)

Completed
  • Healthy Subjects
  • Isavuconazonium sulfate IV
  • Isavuconazonium sulfate capsules
  • Baltimore, Maryland
    Parexel International
Dec 22, 2020

Dialysis, Healthy Subjects, Cytomegalovirus Infection Trial in United States (ASP0113, Placebo)

Completed
  • Dialysis
  • +2 more
  • Los Angeles, California
  • +3 more
May 15, 2019

Safety, Pharmacokinetics, Healthy Subjects Trial in Baltimore (Anifrolumab SC injection (300mg), Anifrolumab IV infusion

Completed
Has Results
  • Safety
  • +2 more
  • Anifrolumab SC injection (300mg)
  • +5 more
  • Baltimore, Maryland
    Research Site
Feb 25, 2019

Healthy Subjects Trial in Baltimore, Hackensack (Blood Collection)

Completed
  • Healthy Subjects
  • Blood Collection
  • Baltimore, Maryland
  • +1 more
Mar 16, 2018

Cytochrome P450 CYP3A5 Enzyme Polymorphism, Healthy Subjects, Pharmacokinetics of Maraviroc Trial in Baltimore (Maraviroc)

Completed
  • Cytochrome P450 CYP3A5 Enzyme Polymorphism
  • +2 more
  • Baltimore, Maryland
    The Johns Hopkins University School of Medicine Division of Clin
Apr 2, 2015

Pharmacokinetics of ASP2408, Healthy Subjects Trial in Baltimore (ASP2408, Placebo)

Completed
  • Pharmacokinetics of ASP2408
  • Healthy Subjects
  • Baltimore, Maryland
    Parexel International
May 27, 2014

Pharmacokinetics of Isavuconazole, Healthy Subjects Trial in Baltimore (Isavuconazole, Esomeprazole)

Completed
  • Pharmacokinetics of Isavuconazole
  • Healthy Subjects
  • Baltimore, Maryland
    Parexel Early Phase Clinical Unit
Apr 30, 2014

Pharmacokinetics of Repaglinide, Pharmacokinetics of Caffeine, Healthy Subjects Trial in Baltimore (Isavuconazole, Repaglinide,

Completed
  • Pharmacokinetics of Repaglinide
  • +2 more
  • Baltimore, Maryland
    Parexel Early Phase Clinical Unit
Apr 29, 2014

Healthy Subjects, Pharmacokinetics of ASP2408 Trial in Baltimore (ASP2408, Placebo)

Completed
  • Healthy Subjects
  • Pharmacokinetics of ASP2408
  • Baltimore, Maryland
    PAREXEL International
Apr 25, 2014

Healthy Subjects Trial in Baltimore (ALXN1007)

Completed
  • Healthy Subjects
  • Baltimore, Maryland
    PAREXEL Baltimore EPCU
Mar 28, 2014

Bioavailability of ASP015K, Healthy Subjects, Pharmacokinetics of ASP015K Trial in Baltimore (ASP015K)

Completed
  • Bioavailability of ASP015K
  • +3 more
  • Baltimore, Maryland
    Parexel - Early Phase Clinical Unit
Sep 13, 2013

Healthy Subjects Trial in Glendale, Baltimore (Placebo, mirabegron, moxifloxacin)

Completed
  • Healthy Subjects
  • Placebo
  • +2 more
  • Glendale, California
  • +1 more
Jul 1, 2013

Healthy Subjects, Dyslipidaemias Trial in Baltimore (GSK256073A tablets)

Completed
  • Healthy Subjects
  • Dyslipidaemias
  • GSK256073A tablets
  • Baltimore, Maryland
    GSK Investigational Site
May 31, 2012

Healthy Subjects, Dyslipidaemias Trial in Baltimore (GSK256073A tablets + IR niacin tablets)

Completed
  • Healthy Subjects
  • Dyslipidaemias
  • GSK256073A tablets + IR niacin tablets
  • Baltimore, Maryland
    GSK Investigational Site
Apr 26, 2012

Healthy Subjects, Infection, Human Immunodeficiency Virus Trial in Baltimore (darunavir/ritonavir, lopinavir/ritonavir,

Completed
  • Healthy Subjects
  • Infection, Human Immunodeficiency Virus
  • Baltimore, Maryland
    GSK Investigational Site
Nov 2, 2010

Healthy Subjects Trial in Baltimore (GSK1349572 250 mg, Placebo Suspension, Moxifloxacin 400 mg)

Completed
  • Healthy Subjects
  • GSK1349572 250 mg
  • +2 more
  • Baltimore, Maryland
    GSK Investigational Site
Jan 21, 2010

Healthy Subjects Trial in Baltimore, Buffalo (fosamprenavir + ritonavir + methadone)

Completed
  • Healthy Subjects
  • fosamprenavir + ritonavir + methadone
  • Baltimore, Maryland
  • +1 more
Feb 19, 2009

Healthy Subjects Trial in Baltimore (AV650)

Completed
  • Healthy Subjects
  • Baltimore, Maryland
    SNBL Clinical Pharmacology Center
Feb 27, 2007